Close

Notable Analyst Rating Changes 10/25: (MKC) (FE) (CHK) Upgraded; (VFC) (ARIA) (OCN) Downgraded Oct 25, 2016 10:10AM
Chardan Capital Keeps ARIAD (ARIA) at 'Neutral'; Q3 Results Top on Lower R&D Expenses Nov 6, 2014 09:10AM
Chardan Affirms ARIAD (ARIA) at 'Buy'; Narrower Label Impacts Iclusig Usage Aug 7, 2014 10:26AM
Pre-Open Stock Movers 3/25: (GALT) (ECYT) (RAX) Higher; (IDN) (HIMX) (GIII) Lower (more...) Mar 25, 2014 09:27AM
Chardan Capital Markets Downgrades ARIAD Pharmaceuticals (ARIA) to Neutral Feb 26, 2014 07:13AM


Dec 23, 2013 10:40AM Notable Analyst Rating Changes 12/23: (ARIA) (LPSN) (FIVE) Upgraded; (MU) (BBRY) (NMM) Downgraded
Dec 23, 2013 09:34AM Pre-Open Stock Movers 12/23: (DRCO) (XRTX) (APPL) Higher; (TSRO) (MU) (TIF) Lower (more...)
Dec 23, 2013 08:09AM UPDATE: Chardan Capital Markets Upgrades ARIAD (ARIA) to Buy as Iclusig Returns to U.S.
Oct 10, 2013 10:49AM Notable Analyst Rating Changes 10/10: (DFS) (HPQ) (SSYS) Upgraded; (ARIA) (RT) (HUBG) Downgraded
Oct 10, 2013 08:05AM Chardan Capital Markets Downgrades ARIAD Pharmaceuticals (ARIA) to Neutral
Sep 30, 2013 10:24AM Notable Analyst Rating Changes 09/30: (BBRY) (CIT) (CMG) Upgraded; (IP) (ICI) (ARIA) Downgraded
Sep 4, 2013 11:00AM Notable Analyst Rating Changes 09/04: (MET) (NSU) (CBS) Upgraded; (MSFT) (VVUS) (ARCP) Downgraded
Sep 4, 2013 08:11AM Chardan Capital Starts ARIAD Pharmaceuticals (ARIA) at Buy